Christina M Lill1, Johnni Hansen2,3, Jørgen H Olsen2, Harald Binder4, Beate Ritz3, Lars Bertram1,5. 1. Platform for Genome Analytics, Institutes of Neurogenetics & Integrative and Experimental Genomics, University of Lübeck, Lübeck, Germany. 2. Institute of Cancer Epidemiology, Danish Cancer Society Research Center, Copenhagen, Denmark. 3. Department of Epidemiology and Environmental Sciences, School of Public Health, University of California, Los Angeles, California, USA. 4. Institute for Medical Biostatistics, Epidemiology and Informatics (IMBEI), University Medical Center Mainz, Mainz, Germany. 5. School of Public Health, Faculty of Medicine, The Imperial College of Science, Technology, and Medicine, London, UK.
Abstract
BACKGROUND: The aim of this study was to assess whether recently identified Parkinson's disease (PD) risk genes also influence age at onset in PD. METHODS: We genotyped 23 single-nucleotide polymorphisms in 1,526 Danish PD patients and performed linear regression analyses with age at onset. The combined impact of PD risk loci on age at onset was assessed by linear regression analyses using a weighted genetic risk score. RESULTS: The strongest effects were observed with rs12726330 in GBA (beta = -3.63, P = 2.0 × 10(-5) ) and rs34311866 in TMEM175/GAK (beta = -1.19, P = 4.0 × 10(-3) ), corresponding to a 3.6-y and 1.2-y decrease of age at onset per risk allele, respectively. The weighted genetic risk score yielded significant association with reduced onset age (P = 3.98 × 10(-3) ), although the variance explained was small (0.6%), and the effect was mostly driven by polymorphisms in GBA and TMEM175/GAK. CONCLUSIONS: Overall, our study indicates that GBA and TMEM175/GAK significantly alter age at onset in PD.
BACKGROUND: The aim of this study was to assess whether recently identified Parkinson's disease (PD) risk genes also influence age at onset in PD. METHODS: We genotyped 23 single-nucleotide polymorphisms in 1,526 Danish PDpatients and performed linear regression analyses with age at onset. The combined impact of PD risk loci on age at onset was assessed by linear regression analyses using a weighted genetic risk score. RESULTS: The strongest effects were observed with rs12726330 in GBA (beta = -3.63, P = 2.0 × 10(-5) ) and rs34311866 in TMEM175/GAK (beta = -1.19, P = 4.0 × 10(-3) ), corresponding to a 3.6-y and 1.2-y decrease of age at onset per risk allele, respectively. The weighted genetic risk score yielded significant association with reduced onset age (P = 3.98 × 10(-3) ), although the variance explained was small (0.6%), and the effect was mostly driven by polymorphisms in GBA and TMEM175/GAK. CONCLUSIONS: Overall, our study indicates that GBA and TMEM175/GAK significantly alter age at onset in PD.
Authors: Sara Bandrés-Ciga; Timothy Ryan Price; Francisco Javier Barrero; Francisco Escamilla-Sevilla; Javier Pelegrina; Sampath Arepalli; Dena Hernández; Blanca Gutiérrez; Jorge Cervilla; Margarita Rivera; Alberto Rivera; Jing-Hui Ding; Francisco Vives; Michael Nalls; Andrew Singleton; Raquel Durán Journal: Neurobiol Aging Date: 2016-06-11 Impact factor: 4.673
Authors: Victoria Berge-Seidl; Lasse Pihlstrøm; Zbigniew K Wszolek; Owen A Ross; Mathias Toft Journal: Neurobiol Aging Date: 2018-09-22 Impact factor: 4.673
Authors: Cornelis Blauwendraat; Karl Heilbron; Costanza L Vallerga; Sara Bandres-Ciga; Rainer von Coelln; Lasse Pihlstrøm; Javier Simón-Sánchez; Claudia Schulte; Manu Sharma; Lynne Krohn; Ari Siitonen; Hirotaka Iwaki; Hampton Leonard; Alastair J Noyce; Manuela Tan; J Raphael Gibbs; Dena G Hernandez; Sonja W Scholz; Joseph Jankovic; Lisa M Shulman; Suzanne Lesage; Jean-Christophe Corvol; Alexis Brice; Jacobus J van Hilten; Johan Marinus; Johanna Eerola-Rautio; Pentti Tienari; Kari Majamaa; Mathias Toft; Donald G Grosset; Thomas Gasser; Peter Heutink; Joshua M Shulman; Nicolas Wood; John Hardy; Huw R Morris; David A Hinds; Jacob Gratten; Peter M Visscher; Ziv Gan-Or; Mike A Nalls; Andrew B Singleton Journal: Mov Disord Date: 2019-04-07 Impact factor: 10.338
Authors: Sara Bandres-Ciga; Sara Saez-Atienzar; Luis Bonet-Ponce; Kimberley Billingsley; Dan Vitale; Cornelis Blauwendraat; Jesse Raphael Gibbs; Lasse Pihlstrøm; Ziv Gan-Or; Mark R Cookson; Mike A Nalls; Andrew B Singleton Journal: Mov Disord Date: 2019-01-24 Impact factor: 10.338